Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.8%

2 terminated/withdrawn out of 72 trials

Success Rate

95.9%

+9.4% vs industry average

Late-Stage Pipeline

3%

2 trials in Phase 3/4

Results Transparency

0%

0 of 47 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
22(91.7%)
Phase 3
2(8.3%)
24Total
N/A(22)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (72)

Showing 20 of 72 trials
NCT04923958Not ApplicableRecruiting

Rapid Research in Diagnostics Development for TB Network

Role: collaborator

NCT07530406Recruiting

Performance, Acceptability, and Usability of a Novel Rapid Lateral Flow Test for Detecting Neisseria Gonorrhoeae in Pregnant and Symptomatic Women Attending Clinics in South Africa.

Role: collaborator

NCT07456969Not Yet Recruiting

Non-invasive Malaria Diagnostic Data Collection in Ethiopia

Role: lead

NCT05117788Active Not Recruiting

Bioneer Q-RFIA Clinical Evaluation

Role: lead

NCT05220163Not ApplicableActive Not Recruiting

Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19

Role: collaborator

NCT04666311Completed

Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis

Role: collaborator

NCT07163143Phase 3Not Yet Recruiting

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

Role: collaborator

NCT05944718Not ApplicableCompleted

Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in South Africa

Role: lead

NCT05175794Completed

Triage Test for All Oral DR-TB Regimen (TRiAD Study)

Role: collaborator

NCT06019052Not Yet Recruiting

Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study

Role: lead

NCT04568967Not ApplicableCompleted

TB-CAPT EXULTANT - HIV

Role: lead

NCT04568954Not ApplicableCompleted

TB-CAPT CORE Truenat Trial

Role: lead

NCT04825327Completed

Predicting the Future: Incipient Tuberculosis

Role: collaborator

NCT06118749Terminated

Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study

Role: lead

NCT04567368Active Not Recruiting

TB-CAPT MTB/XDR Study

Role: lead

NCT06213051Unknown

Comparison of Self-collection Using Dry Compared to Wet Swabs for HPV Detection

Role: lead

NCT05257564Not ApplicableCompleted

Cardiometabolic Devices Accuracy Study

Role: lead

NCT06225700Completed

Clinical Validation of Novel Malaria Diagnostic Tools for POC Point-of-Care Testing

Role: lead

NCT05405296Unknown

Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2)

Role: lead

NCT03394976Withdrawn

Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum Malaria

Role: lead